The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.

Bosman, G; Langemeijer, S M C; Hebeda, K M; Raemaekers, J M M; Pickkers, P; van der Velden, W J F M

Bosman, G; Langemeijer, S M C; Hebeda, K M; Raemaekers, J M M; Pickkers, P; van der Velden, W J F M.

Neth J Med ; 67(8): 364-5, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19767670

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/administration & dosage; Epstein-Barr Virus Infections/drug therapy; Herpesvirus 4, Human; Immunologic Factors/therapeutic use; Lymphohistiocytosis, Hemophagocytic/drug therapy; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cyclophosphamide/therapeutic use; Doxorubicin/therapeutic use; Epstein-Barr Virus Infections/virology; Female; Humans; Lymphohistiocytosis, Hemophagocytic/virology; Prednisone/therapeutic use; Rituximab; Vincristine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Herpesvirus 4, Human / Epstein-Barr Virus Infections / Lymphohistiocytosis, Hemophagocytic / Immunologic Factors / Antibodies, Monoclonal / Antineoplastic Agents Limits: Adult / Female / Humans Language: En Journal: Neth J Med Year: 2009 Document type: Article

Search on Google

XML

PubMed Links